
| | Public Offering Price | | | Underwriting Discount | | | Proceeds, Before Expenses, to Thermo Fisher | |
Per 2025 note | | | 100% | | | 0.300% | | | 99.700% |
2025 notes total | | | ¥22,300,000,000 | | | ¥66,900,000 | | | ¥22,233,100,000 |
Per 2027 note | | | 100% | | | 0.350% | | | 99.650% |
2027 notes total | | | ¥28,900,000,000 | | | ¥101,150,000 | | | ¥28,798,850,000 |
Per 2029 note | | | 100% | | | 0.400% | | | 99.600% |
2029 notes total | | | ¥4,700,000,000 | | | ¥18,800,000 | | | ¥4,681,200,000 |
Per 2032 note | | | 100% | | | 0.450% | | | 99.550% |
2032 notes total | | | ¥6,300,000,000 | | | ¥28,350,000 | | | ¥6,271,650,000 |
Per 2042 note | | | 100% | | | 0.700% | | | 99.300% |
2042 notes total | | | ¥14,600,000,000 | | | ¥102,200,000 | | | ¥14,497,800,000 |
Per 2052 note | | | 100% | | | 0.800% | | | 99.200% |
2052 notes total | | | ¥33,300,000,000 | | | ¥266,400,000 | | | ¥33,033,600,000 |
| | | | | | ||||
Total | | | ¥110,100,000,000 | | | ¥583,800,000 | | | ¥109,516,200,000 |
Citigroup | | | Mizuho | | | MUFG | | | SMBC Nikko |